Blue Bell Private Wealth Management’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-200
Closed -$1K – 852
2022
Q1
$1K Buy
+200
New +$691 ﹤0.01% 803

Other funds holding LAB

Blue Bell Private Wealth Management's LAB Position: Q2 2022 in Review

Blue Bell Private Wealth Management sold out of Standard BioTools (LAB) in Q2 2022, closing a stake of 200 shares — an estimated $1K sold.

Blue Bell Private Wealth Management first reported a position in LAB in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 86 funds tracked by Wall St. Rank hold LAB as of Q2 2022.

  • Blue Bell Private Wealth Management reported no remaining Standard BioTools position as of Q2 2022 after selling out during the quarter.
  • Blue Bell Private Wealth Management sold 200 Standard BioTools shares in Q2 2022, an estimated $1K.
  • Blue Bell Private Wealth Management first reported a position in Standard BioTools in Q1 2022 and held it in 1 quarter.
  • Blue Bell Private Wealth Management's Standard BioTools position peaked at $1K in Q1 2022.
  • 86 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2022.

Based on Blue Bell Private Wealth Management's 13F filing for Q2 2022, filed 2 Aug 2022.